CANNARA BIOTECH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.84 CAD | -1.18% |
|
+2.44% | +1.20% |
| Jan. 29 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
| 2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Companyâs brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.
Calendar
2024-07-24
- Q3 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +1.20% | 55.24M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| -42.17% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Cannara Biotech Q4 EPS Unchanged at $0.01 Vs Year Ago; Revenue $11.9 Million Vs $6.5 Million
